Stocks and Investing Stocks and Investing
Thu, July 18, 2024
Wed, July 17, 2024

Salveen Richter Maintained (APLS) at Strong Buy with Decreased Target to $77 on, Jul 17th, 2024


Published on 2024-10-28 12:32:23 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $90 to $77 on, Jul 17th, 2024.

Salveen has made no other calls on APLS in the last 4 months.



There are 9 other peers that have a rating on APLS. Out of the 9 peers that are also analyzing APLS, 4 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Biren Amin of "Piper Sandler" Initiated at Hold and Held Target at $46 on, Friday, May 31st, 2024
  • Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $48 on, Thursday, May 23rd, 2024
  • Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $52 on, Monday, April 29th, 2024
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $57 on, Wednesday, April 17th, 2024


These are the ratings of the 5 analyists that currently disagree with Salveen


  • Colleen Kusy of "Baird" Maintained at Buy and Held Target at $100 on, Friday, June 28th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $92 on, Tuesday, May 28th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $85 on, Wednesday, May 8th, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Wednesday, May 8th, 2024
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Wednesday, May 8th, 2024

Contributing Sources